Koers Molecular Pharmacology (USA), Ltd. Other OTC
Aandelen
MLPH
US60852T1097
Biotechnologie & Medisch Onderzoek
Omzet 2013 | - | Omzet 2014 | - | Marktkapitalisatie | 1,12 mln. 1,03 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2013 | - 0 | Nettowinst (verlies) 2014 | - 0 | EV/omzet 2013 | - |
Nettoschuld 2013 | 2,04 mln. 1,88 mln. | Nettoschuld 2014 | 2,2 mln. 2,03 mln. | EV/omzet 2014 | - |
K/w-verhouding 2013 |
-5,85
x | K/w-verhouding 2014 |
-9,54
x | Werknemers | - |
Dividendrendement 2013 * |
-
| Dividendrendement 2014 |
-
| Vrij verhandelbaar | 99% |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+9,58% | 115 mld. | |
+12,41% | 107 mld. | |
-2,59% | 21,6 mld. | |
-12,38% | 22,31 mld. | |
-5,29% | 19,19 mld. | |
-3,35% | 18,23 mld. | |
-38,57% | 17,62 mld. | |
+7,51% | 14,26 mld. | |
+35,67% | 12,37 mld. |